Form 8-K - Current report:
SEC Accession No. 0001171843-24-004324
Filing Date
2024-08-01
Accepted
2024-08-01 07:31:17
Documents
41
Period of Report
2024-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_080124.htm   iXBRL 8-K 15333
2 PRESS RELEASE exh_991.htm EX-99.1 90638
3 EXHIBIT 99.2 exh_992.htm EX-99.2 34338
4 exh992_01.jpg GRAPHIC 104365
5 exh992_02.jpg GRAPHIC 218668
6 exh992_03.jpg GRAPHIC 115130
7 exh992_04.jpg GRAPHIC 168390
8 exh992_05.jpg GRAPHIC 97362
9 exh992_06.jpg GRAPHIC 121327
10 exh992_07.jpg GRAPHIC 163149
11 exh992_08.jpg GRAPHIC 122377
12 exh992_09.jpg GRAPHIC 90310
13 exh992_10.jpg GRAPHIC 120427
14 exh992_11.jpg GRAPHIC 150400
15 exh992_12.jpg GRAPHIC 177007
16 exh992_13.jpg GRAPHIC 209466
17 exh992_14.jpg GRAPHIC 198851
18 exh992_15.jpg GRAPHIC 162947
19 exh992_16.jpg GRAPHIC 211028
20 exh992_17.jpg GRAPHIC 178899
21 exh992_18.jpg GRAPHIC 116616
22 exh992_19.jpg GRAPHIC 90354
23 exh992_20.jpg GRAPHIC 148974
24 exh992_21.jpg GRAPHIC 134986
25 exh992_22.jpg GRAPHIC 181671
26 exh992_23.jpg GRAPHIC 118549
27 exh992_24.jpg GRAPHIC 106972
28 exh992_25.jpg GRAPHIC 86260
  Complete submission text file 0001171843-24-004324.txt   5313678

Data Files

Seq Description Document Type Size
29 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3003
30 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25598
31 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
32 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
43 EXTRACTED XBRL INSTANCE DOCUMENT f8k_080124_htm.xml XML 3312
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 241164291
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)